Our articles provide quick read summaries to help keep you informed and looking forward with industry insights.
ROP is one of the leading causes of childhood blindness globally. The availability of an FDA approved medication for ROP represents an important alternative for preterm infants and their parents...
Learn more about the fundamentals of PCWG3 response criteria, PSMA PET/CT response criteria, data collection, and response assessment....
Learn more about bone scans and PSMA PET/CT scans in prostate cancer, including procedure overviews and tips for success. ...
Learn more about ADCs, a new and potentially favorable approach for treating prostate cancer....
Learn about the most common types of Decentralized Clinical Trials (DCTs) and how to make their vast data sets actionable with secure, cloud-based data platforms....
Learn about the rules and principles of iRECIST, imaging endpoints, and special considerations for using iRECIST response criteria....
MERIT attended the WG-09: Ophthalmology meeting at AAO 2022. Read our article for several key takeaways. ...
MERIT’s webinar provides key takeaways that are important for oncology imaging clinical trials along with insights on how an Imaging Core Lab (ICL) can help you address imaging trial challenges. ...
Learn about the principles and recommendations of RANO response criteria for high grade glioma (HGG) and the imaging endpoint information that needs to be collected for clinical trials....
In this article, learn about the key role that IRCs play in imaging clinical trials....
Key takeaways from MERIT's Webinar: RECIST 1.1 and Oncology Trial Endpoints. ...
Imaging provides an unbiased, structural assessment of many disease states, which is a complement to functional outcome measures...